Titled “Simultaneous prenatal cfDNA screening of aneuploidy, recessive single-gene conditions, and fetomaternal blood compatibility,” the study used nearly 500 samples to assess the multiple ...

The World Health Organization (WHO) estimates that 10.5% of medicines worldwide in low- and middle-income countries are substandard or are falsified (i.e., fake). These medicines and vaccines fail to ...

•Task NASS, Nigerians to resist dictatorship, disruption in healthcareBy Enyeribe EjioguA group, Patriotic Medical Laboratory Scientists, PMLS, has raised alarm over the proposed Medical and Dental ...

XingImaging has been selected as the Imaging Core Lab for the Alzheimer's Tau Platform (ATP)--a groundbreaking, multi-arm, randomized Phase II clinical trial designed to simultaneously investigate ...

Regenerative Medicine Advanced Therapy (RMAT) designation requests update submitted to FDA with recent biomarker data ...

Vaxcyte Incorporated (NASDAQ:PCVX) is one of the 17 biotechnology stocks with more than 50% upside. On January 23, Cantor Fitzgerald maintained its Overweight rating on Vaxcyte Incorporated ...

Extensive clinical validation and deployment are what remain to make it routine, according to University of New South Wales Scientia Professor Justin Gooding.

Researchers publishing in ACS’ Journal of Agricultural and Food Chemistry conducted an initial food safety study to identify ...

Release summary: Molecular Instruments launches fully ambient-temperature HCR (TM) Pro RNA-ISH on the BOND-III, marking a new generation of clinical-grade RNA-ISH designed to reduce heat-driven ...

Orbiton Theragnostics to offer pre-clinical & clinical services, contract research & CDMO, isotope supply, and ...

Molecular Instruments® (MI), inventor of the HCR™ technology, today announced the availability of fully ambient-temperature ...

Data from Phase 2a study demonstrated the first clinical proof of concept for alpibectir in combination with ethionamide (AlpE) in the treatment ...